AbbVie Statistics
Total Valuation
AbbVie has a market cap or net worth of CAD 744.99 billion. The enterprise value is 845.99 billion.
Important Dates
The last earnings date was Friday, October 30, 2026.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | Jan 15, 2027 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 0.07% |
| Owned by Institutions (%) | 76.47% |
| Float | 1.76B |
Valuation Ratios
The trailing PE ratio is 50.71 and the forward PE ratio is 18.83.
| PE Ratio | 50.71 |
| Forward PE | 18.83 |
| PS Ratio | 7.95 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 27.81 |
| P/OCF Ratio | 26.12 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 18.34, with an EV/FCF ratio of 31.58.
| EV / Earnings | 57.84 |
| EV / Sales | 8.96 |
| EV / EBITDA | 18.34 |
| EV / EBIT | 24.45 |
| EV / FCF | 31.58 |
Financial Position
The company has a current ratio of 0.87
| Current Ratio | 0.87 |
| Quick Ratio | 0.56 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.52 |
| Debt / FCF | 4.31 |
| Interest Coverage | 8.12 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 10.74% |
| Return on Invested Capital (ROIC) | 19.72% |
| Return on Capital Employed (ROCE) | 23.13% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 1.64M |
| Profits Per Employee | 256,608 |
| Employee Count | 57,000 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 3.39 |
Taxes
In the past 12 months, AbbVie has paid 3.50 billion in taxes.
| Income Tax | 3.50B |
| Effective Tax Rate | 19.24% |
Stock Price Statistics
The stock price has increased by +23.58% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +23.58% |
| 50-Day Moving Average | 38.19 |
| 200-Day Moving Average | 33.58 |
| Relative Strength Index (RSI) | 62.33 |
| Average Volume (20 Days) | 4,182 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.29 |
Income Statement
In the last 12 months, AbbVie had revenue of CAD 93.72 billion and earned 14.63 billion in profits. Earnings per share was 0.81.
| Revenue | 93.72B |
| Gross Profit | 69.09B |
| Operating Income | 34.33B |
| Pretax Income | 18.19B |
| Net Income | 14.63B |
| EBITDA | 45.22B |
| EBIT | 34.33B |
| Earnings Per Share (EPS) | 0.81 |
Full Income Statement Balance Sheet
The company has 15.30 billion in cash and 115.44 billion in debt, with a net cash position of -100.15 billion.
| Cash & Cash Equivalents | 15.30B |
| Total Debt | 115.44B |
| Net Cash | -100.15B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -6.44B |
| Book Value Per Share | -0.36 |
| Working Capital | -7.98B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 28.52 billion and capital expenditures -1.73 billion, giving a free cash flow of 26.79 billion.
| Operating Cash Flow | 28.52B |
| Capital Expenditures | -1.73B |
| Depreciation & Amortization | 10.96B |
| Net Borrowing | 17.41B |
| Free Cash Flow | 26.79B |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 73.72%, with operating and profit margins of 36.63% and 15.67%.
| Gross Margin | 73.72% |
| Operating Margin | 36.63% |
| Pretax Margin | 19.41% |
| Profit Margin | 15.67% |
| EBITDA Margin | 48.25% |
| EBIT Margin | 36.63% |
| FCF Margin | 28.39% |
Dividends & Yields
This stock pays an annual dividend of 0.97, which amounts to a dividend yield of 2.37%.
| Dividend Per Share | 0.97 |
| Dividend Yield | 2.37% |
| Dividend Growth (YoY) | -18.10% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 117.37% |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 2.37% |
| Earnings Yield | 1.97% |
| FCF Yield | 3.60% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | |
| Graham Formula Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AbbVie has an Altman Z-Score of 2.39 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.39 |
| Piotroski F-Score | 7 |